Portugal became the new Costa Rica during the Covid epidemic. Lax lockdowns and no need for vaccine certificates, combined with plenty of nature and freedom for global nomads made Portugal the go-to place for people around the globe. Full of entrepreneurial spirit that other countries may have lost Portugal now aims to be a medical cannabis hub of Europe and the world. America’s complicated relationships with Federal cannabis laws make doing business there complicated. Canada’s market is saturated with so many products and companies. Can the climate of Portugal do it better?
Canadian-founded and American headquartered Tilray is one of the companies doing business in Portugal. Tilray (Nasdaq: TLRY; TSX: TLRY) receives its second approval for a new medical cannabis extract in Portugal: Tilray Oral Solution THC10:CBD10. It’s a product that is built with half and half, CBD and THC.
Denise Faltischek, Chief Strategy Officer and Head of International at Tilray said: “This is a significant step towards meeting the critical needs of patient care and providing high-quality cannabis products and therapeutic options to those with specific medical conditions. The approval of this oral cannabis solution in Portugal is a testament to Tilray’s global commitment to increasing safe and regulated access to medical cannabis products for patients in need.”
Related: How Alan Shackelford changed cannabis into medicine
Tilray Medical continues to be a global leader in the medical cannabis industry, offering a diverse portfolio of EU-GMP certified medicinal cannabis products. With operations extending over 20 countries, Tilray Medical is dedicated to supporting medical cannabis patient care worldwide through quality products accessible via healthcare practitioners. Its business in Portugal is a stepping stone to the rest of the EU.
Tilray Medical grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in over 20 countries and across five continents.
After we published this article, we feel a reader inquiry warrants an update. A cannabis grower with a nationally registered brand tells Green Prophet: “But what you don’t hear in your story is how littered with clandestine growers are in the police services.”
People planning on starting a cannabis business in Portugal beware
